共 15 条
[1]
Molecular effects of HMGCoA reductase inhibitors on smooth muscle cell proliferation. Eschert H,Pawlus E,Breithardt G. Journal of the American College of Cardiology . 2001
[2]
Do ACE inhibitor or ARBs limit restenosis after stenting. Ellis S G. Journal of Invasive Cardiology . 2001
[3]
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Takemoto M,Liao J k. Arteriosclerosis and Thrombosis . 2001
[4]
Mechanism of neointima formation an remodeling in the Porcin coronary artery. Christen T,Verin V,Bochaton-Piallat ML,et al. Circulation . 2001
[5]
Increased Creactive protein levels in patients with in stent restenosis and its implications. Angioi M,Abdelmouttaleb L,Rodriguez R M,et al. The American Journal of Cardiology . 2001
[6]
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowing: new concepts for cardiovascular disease. Lefer A M,Scalia R,Lefer D,et al. Cardiovascular Research . 2001
[7]
Rapid reduction in creactive protein with Cerivastatin among 785 patients with primary hypercholesterolemia. Ridker P M,Rifai N,Lowenthal S P,et al. Circulation . 2001
[8]
Pathophysiology of vascular endothelium and circulating platelets: implications for coronary revascularisation and treatment. Amoroso G,van Veldhuisen D J,Tio R A,et al. International Journal of Cardiology . 2001
[9]
Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. Porter K E,Naik J,Turner N A,et al. Journal of Vascular Surgery . 2002
[10]
Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PIA2 allele of the platelet glycoprotein IIIa gene. Walter D H,Schachinger V,Elsner M,et al. European Heart Journal . 2001